CORRELATION OF SERUM HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND HOMOCYSTEINE LEVEL IN PATIENT WITH ACUTE MYOCARDIAL INFARCTION
DOI:
https://doi.org/10.24293/ijcpml.v25i1.1515Keywords:
High-density lipoprotein, homocysteine, acute myocardial infarctionAbstract
Acute Myocardial Infarction (AMI), one of the primary manifestation of coronary heart disease, is a significat cause of death worldwide. Hyperhomocysteinemia, a risk factor for cardiovascular disease, is caused by nutritional or genetic disturbances in homocysteine metabolism. The role of hyperhomocysteinemia in altered lipid metabolism presumed holds the key to an increased risk of cardiovascular disease. Hyperhomocysteinemia causes the reduction of serum High-Density Lipoprotein (HDL) cholesterol level by inhibiting hepatic synthesis of apo-A1 (significant apolipoprotein HDL). The aim of this study was to know the correlation between hyperhomocysteinemia and decreased HDL cholesterol levels for the management of cardiovascular disease risk factors. This research was an analytical study with cross-sectional design in 40 patients AMI who meet the inclusion and exclusion criteria and conduct blood test at the Central Laboratory of Hospital Dr. M. Djamil Padang and Biomedical Laboratory Faculty of Medicine Andalas University. The study was conducted in May 2016-Agustus 2017. Homocysteine level was measured by ELISA method. High-Density Lipoprotein level was performed by enzymatic colorimetric method. Data were analyzed by Spearman's correlation test. Research subjects were 40 people with male gender 30 (75%) and female 10 (25%), mean age 61.08 (11.09) year. The mean level of HDL cholesterol in patients with AMI is 41.93 ± 13.12 mg/dL. The mean level of homocysteine in patients with AMI is 25.36 ± 22.2 µmol/L. Spearman's correlation test showed a strong correlation between the levels of homocysteine and HDL cholesterol with r=-0.603 and p<0.01.
Downloads
References
WHO. World data table in the atlas of heart disease and stroke.2003. Available atwww.who.int/cardiovascular_disease/en/cvd_atlas. (Accessed Date 20 May 2016).
Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Ma¨ho¨nen M, Lisheng L, et al. World Health Organization definition of myocardial infarction. 2008–09 Revision. Int. J. Epidemiol. Advance Access, 2010; 1-8.
Delima, Mihardja L, Siswoyo H. Prevalensi dan faktor determinan penyakit jantung di Indonesia. Bul. Penelit. Kesehat, 2009; 37(3): 142 – 159.
De Farias Leal, Palmeiraa AC, Almeida De Castrob GM, Da Silva Simíµesb MO, Ramosb AT, Medeirosbet CC, et al. Homocysteine: cardiovascular risk factor in children and adolescents?'. in Rev Assoc Med Bras, 2013; 59(6): 622–628.
Martí-Carvajal AJ, Solí I, Lathyris D. Homocysteine-lowering interventions for preventing cardiovascular events (review). Cochrane Database of Systematic Reviews, 2015; 1-3.
Ray JG. Review: Elevated homocysteine levels are modestly associated with increased ischemic heart disease and stroke risk. JAMA, 2002; 288: 2015-22.
Lievers K, Kluijtmans L, Blom HJ. Genetics of hyperhomocysteinemia in cardiovascular disease. Ann Clin Biochem, 2003; 40: 46–59.
Kumar J, Jayaraman S, Muralidharan N. Homocysteine-A potent modulator. Biotechnology and Molecular Biology Review, 2012; 7(1): 1-4.
Al-Obaidi MK, Stubbs PJ, Collinson P, Conroy R, Graham I, Mark I, et al. Elevated homocysteine levels are associated with an increased ischemic myocardial injury in acute coronary syndromes. Journal of the American College of Cardiology, 2000; 36(4): 1-6.
Holven KB, Aukrust I, Retterstí¸l K, Otterdal K, Bjerkeli V, Ose L, et al. The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects. J. Nutr, 2008; 138: 2070–2075.
Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: A systematic review and meta-analysis. Mayo Clin Proc, 2008; 83(11): 1203-1212.
Barter P. The role of HDL-cholesterol in preventing atherosclerotic disease. European Heart Journal Supplements, 2005; 7: F4–F8.
Devlin AM, Lentz SR. Apo-A1; A missing link between homocysteine and lipid metabolism?. Circ Res, 2006; 98: 431-433.
Haas R. Is homocysteine making you sick?. Life Extension Magazine, 2009. Available athttp://www.lifeextension.com. (Accessed date 28 May 2016).
Obeid R, Herrmann W. Homocysteine and lipids: S-Adenosyl methionine as a key intermediate. FEBS Letters, 2009; 583: 1215–1225.
PERKI. Pedoman tatalaksana sindrom koroner akut. Jakarta, Perhimpunan Dokter Spesialis Kardiovaskuler Indonesia (PERKI), 2015; 39-40.
Qujeq D, Omran TS, Hosini L. Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein in the serum of patients with myocardial infarction. Clin Biochem, 2001; 34(2): 97-101.
Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance. Circ Res, 2006; 99(6): 598–606.
Mikael LG, Genest J, Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res, 2006; 98: 564-571.
Samara I, Karikas GA, Kalkani E, Tzimogianni A, Bournousouzis N, Fytou-Pallikari A, et al. Negative correlations of serum total-homocysteine and HDL-c levels in ICU patients. Health Science Journal, 2010; 4(3): 189-192.
Abu Sedo RR. Homocysteine levels of cardiovascular disease patients attending the cardiac unit at El Shifa Hospital, Gaza Strip. Faculty of Medicine Islamic University of Gaza, 2012; 1-103.
Ahmadi A, Soori H, Etemad K. Current status of the clinical epidemiology of myocardial infarction in men and women: A national cross-sectional study in Iran. International Journal of Preventive Medicine, 2015; 1-8.
Mitchell RN, Schoen FJ. Blood vessel. Robbins and Cotran pathologic basic of disease. 8thEd., Philadelphia, Elsevier Saunders, 2010; 542-570.
Rains MG, Laney CA, Bailey AL, Campbell CL. Biomarkers of acute myocardial infarction in the elderly: Troponin and beyond. Clinical Interventions in Aging, 2014; 1081-1090.
Alam N, Khan HILR, Chowdhury AW, Haque MS, Ali MS, Sabah KMN et al. Elevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarction. Bangladesh Med Res Counc Bull, 2012, 38(1): 9-13.
Williams BO. Acute myocardial infarction in the elderly: The review. Journal of The Hongkong Geriatric Society, 2001; 1-5.
Soh J, Josekutty J. Lipids and dyslipoproteinemia. Henry's clinical diagnosis and management by laboratory methods. 21th Ed., Brooklyn, New York, 2011; 227-247.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 1970 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
